RERAX
Price
$57.98
Change
+$0.30 (+0.52%)
Updated
Sep 5 closing price
Net Assets
133.49B
TIGVX
Price
$24.69
Change
+$0.13 (+0.53%)
Updated
Sep 4 closing price
Net Assets
730.14M
Interact to see
Advertisement

RERAX vs TIGVX

Header iconRERAX vs TIGVX Comparison
Open Charts RERAX vs TIGVXBanner chart's image
American Funds EUPAC R1
Price$57.98
Change+$0.30 (+0.52%)
VolumeN/A
Net Assets133.49B
Thornburg International Growth R3
Price$24.69
Change+$0.13 (+0.53%)
VolumeN/A
Net Assets730.14M
RERAX vs TIGVX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RERAX vs. TIGVX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RERAX is a Hold and TIGVX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 133B vs. TIGVX (730M). RERAX pays higher dividends than TIGVX: RERAX (0.23) vs TIGVX (0.00). RERAX was incepted earlier than TIGVX: RERAX (23 years) vs TIGVX (18 years). TIGVX (2.18) is less costly to investors than RERAX (1.57). TIGVX is a more actively managed with annual turnover of: 44.57 vs. RERAX (35.00). TIGVX has a lower initial minimum investment than RERAX: TIGVX (0) vs RERAX (250). RERAX annual gain was more profitable for investors over the last year : 7.44 vs. TIGVX (-3.72). RERAX return over 5 years is better than : 7.30 vs. TIGVX (-9.50).
RERAXTIGVXRERAX / TIGVX
Total Expense Ratio1.571.50105%
Annual Report Gross Expense Ratio1.572.1872%
Fund Existence23 years18 years-
Gain YTD14.97111.240133%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets133B730M18,219%
Annual Yield % from dividends0.230.00-
Returns for 1 year7.44-3.72-200%
Returns for 3 years32.3027.76116%
Returns for 5 years7.30-9.50-77%
Returns for 10 years33.0838.0987%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENTO2.700.05
+1.89%
Entero Therapeutics Inc
BLD435.395.97
+1.39%
TopBuild Corp
IROQ25.41-0.04
-0.14%
IF Bancorp
IOSP85.72-0.14
-0.16%
Innospec
ZKH2.85-0.01
-0.35%
ZKH Group Limited